Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine for Heparin Reversal in AF Ablation
NCT03140631Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of protamine in Atrial fibrillation (AFib) and atrial flutter (AFL) (2 arms), sponsored by University of Michigan. Primary endpoint: Time to Ambulation. Started Mar 2017; status: completed.
02
Drugs
protamine
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT03140631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140631.